Photostability of commercial sunscreens upon sun exposure and irradiation by ultraviolet lamps by Gonzalez, Helena et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Dermatology
Open Access Research article
Photostability of commercial sunscreens upon sun exposure and 
irradiation by ultraviolet lamps
Helena Gonzalez*1, Nils Tarras-Wahlberg2, Birgitta Strömdahl2, 
Asta Juzeniene3, Johan Moan3, Olle Larkö1, Arne Rosén2 and Ann-
Marie Wennberg1
Address: 1Department of Dermatology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden, 2Department of Physics, Göteborg 
University, SE-412 96 Göteborg, Sweden and 3Department of Radiation Biology, Institute for Cancer Research, The Norwegian Radium Hospital, 
Montebello, Oslo, N-0310, Norway
Email: Helena Gonzalez* - helena.gonzalez@vgregion.se; Nils Tarras-Wahlberg - tarras@fy.chalmers.se; 
Birgitta Strömdahl - birgitta.stromdahl.922@student.lth.se; Asta Juzeniene - asta.juzeniene@klinmed.uio.no; 
Johan Moan - johan.moan@labmed.uio.no; Olle Larkö - olle.larko@derm.gu.se; Arne Rosén - arne.rosen@fy.chalmers.se; Ann-
Marie Wennberg - ann-marie.wennberg@vgregion.se
* Corresponding author    
Abstract
Background: Sunscreens are being widely used to reduce exposure to harmful ultraviolet (UV)
radiation. The fact that some sunscreens are photounstable has been known for many years. Since
the UV-absorbing ingredients of sunscreens may be photounstable, especially in the long
wavelength region, it is of great interest to determine their degradation during exposure to UV
radiation. Our aim was to investigate the photostability of seven commercial sunscreen products
after natural UV exposure (UVnat) and artificial UV exposure (UVart).
Methods: Seven commercial sunscreens were studied with absorption spectroscopy. Sunscreen
product, 0.5 mg/cm2, was placed between plates of silica. The area under the curve (AUC) in the
spectrum was calculated for UVA (320–400 nm), UVA1 (340–400 nm), UVA2 (320–340 nm) and
UVB (290–320 nm) before (AUCbefore) and after (AUCafter) UVart (980 kJ/m2 UVA and 12 kJ/m2 of
UVB) and before and after UVnat. If theAUC Index (AUCI), defined as AUCI = AUCafter/AUCbefore,
was > 0.80, the sunscreen was considered photostable.
Results: Three sunscreens were unstable after 90 min of UVnat; in the UVA range the AUCI was
between 0.41 and 0.76. In the UVB range one of these sunscreens was unstable with an AUCI of
0.75 after 90 min. Three sunscreens were photostable after 120 min of UVnat; in the UVA range
the AUCI was between 0.85 and 0.99 and in the UVB range between 0.92 and 1.0. One sunscreen
showed in the UVA range an AUCI of 0.87 after UVnat but an AUCI of 0.72 after UVart. Five of
the sunscreens were stable in the UVB region.
Conclusion: The present study shows that several sunscreens are photounstable in the UVA
range after UVnat and UVart. There is a need for a standardized method to measure photostability,
and the photostability should be marked on the sunscreen product.
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Background
Sunscreens give good protection against sunburn, actinic
keratosis and squamous cell carcinoma. The results for
preventing cutaneous malignant melanoma (CMM) and
basal cell carcinoma are less conclusive [1-3]. One expla-
nation for this can be that UVA radiation (320–400 nm)
plays a role for induction of CMM [4] and that it is mainly
in the UVA range the photodegradation of the sunscreen
occurs. In the present work, commercially available sun-
screens, containing organic chemical and/or inorganic
chemical filters, have been exposed to natural UV (UVnat)
as well as to artificial UV (UVart) in order to study their
photostability.
Previous studies have shown that some sunscreens lose
part of their protection when exposed to UV radiation [5-
10]. Several sunscreen producers claim that their products
give good protection against both UVA and UVB radia-
tion; however, the photostability of the product is rarely
declared. This is also important for the consumer to know
when choosing a sunscreen. Since it has been known for
several years that some products may be photounstable,
one would have expected a large improvement in the pho-
tostability of sunscreen products. Up to now, there is no
standard method for determining photostability of a sun-
screen [6,11,12]. Neither is there an international stand-
ard method for measuring UVA protection, and several
different systems are currently in use [13-16].
The aim of this study was to investigate the photostability
of commercial sunscreen products after UVnat and after
UVart.
Methods
Sunscreens
Seven commercial sunscreens were included, all available
on the Swedish market. Three sunscreens contained only
organic chemical filters, three sunscreens had a combina-
tion of inorganic and organic chemical filters, and one
sunscreen contained solely inorganic chemical filters. In
Table 1 the photoactive compounds of the sunscreens and
the Sun Protection Factor (SPF) of the product are shown.
The sunscreen was weighed and placed between two
plates of polished fused silica (quartz) with diameter 25
mm and thickness 5 mm. The amount applied was 0.5
mg/cm2. The absorbance was too high for proper meas-
urements when the recommended amount of 2 mg/cm2
was applied, causing distortion in the absorption spec-
trum. For this reason a thinner layer was applied. A previ-
ous study has shown that the result were independent
whether an application thickness of 1 or 2 mg/cm2 was
used [17].
Light sources
For UVA radiation, a UVASUN 2000 (MUTZHAS, Ger-
many) was used. The output is mainly between 340 and
400 nm.
For UV radiation (including UVB), an Esshå Corona Mini
(Sweden), equipped with two fluorescent tubes, Philips
TL 12 (20 W), was used. This is a broadband radiation
source from 280 to 380 nm with a major peak at 313 nm.
There are strong mercury peaks at 313 nm and 365 nm.
The irradiance at the exposure plane was measured with
an International Light IL 1350 Radiometer/Photometer
using a probe named SED 240 for UVA and a probe
named SED 015 for UVB radiation. The fluence rate of the
UVA lamp was 820 W/m2 when measured from a distance
of 25 cm. Twenty minutes' exposure gave a dose of 980 kJ/
m2. This corresponds to the UVA dose that reaches the
earth's surface during one sunny summer day in Gothen-
burg [18]. We also measured the spectral distribution of
the UVB lamp. By combining the spectral distribution
with the action spectrum of the probe, the fluence rate of
the UVB radiation was 9.8 W/m2. Twenty minutes of
exposure gave a dose of 12 kJ/m2 UV radiation (including
UVB). This corresponds to 45 Standard Erythema Doses
(SED) when further weighted by the CIE action spectrum
[19]. This is a much higher dose than normal for one sum-
mer day in Gothenburg [18] or what has been reported
from Denmark [20]. In spite of that fact, the majority of
sunscreens showed good stability in the UVB range. In
Table 2 the UV doses reported from the Swedish Metro-
logical and Hydrological Institute (SMHI) are listed.
For UVnat, samples were placed horizontally outdoors
when the weather was sunny. This was done in early July
in Gothenburg (latitude: 57° 42' N). The total exposure
time was 120 min (Table 2) with measurements of the
absorption spectra before exposure and after 30 min, 90
min and 120 min of UVnat. SMHI measures the global
irradiance in many places in Sweden and gives the CIE
erythema weighted UV radiation as well (Table 2).
To eliminate the possibility that the degradation of the
photoactive compounds could be caused by a tempera-
ture increase, control samples of sunscreen between silica
plates were placed on a heating plate for 20 minutes. The
temperature was kept at 50°C ± 2°C, which was the same
as that measured during exposure to the UVA lamp. This
is about 15°C higher than the temperature of the skin.
Spectra were recorded prior to and after heating. The tem-
perature did not influence the degradation since the
absorption spectra did not change after heating.BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
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Spectrometer
In all studies the spectra were recorded by a Cary 4 spec-
trophotometer (Varian, USA). It is a two-beam spectro-
photometer without integrating sphere, which measures
the transmission by scanning over the wavelength range
of interest. Without integrating sphere the measured
absorbance includes also some scattered radiation. There-
fore, the spectra of samples with inorganic filters, which
scatter light, may show a too high absorbance.
Area under the curve index (AUCI)
The AUC for UVA, UVA1 (340–400 nm), UVA2 (320–340
nm) and UVB was calculated for each spectrum before
(AUCbefore) and after (AUCafter) UVart (980 kJ/m2 UVA
Table 2: The dose of natural UV radiation the investigated sunscreens received
Sunscreen Exposure time (min) UVA radiation (kJ/m2) Erythemal effective radiation (J/m2)S E D
1 30 54 **
90 180 **
120 260 **
2 30 54 100 1
90 180 410 4.1
120 260 610 6.1
3 30 65 140 1.4
90 210 530 5.3
120 280 730 7.3
4 30 65 **
90 210 **
120 280 **
5 30 ** **
90 ** **
120 210 **
6 30 47 140 1.4
90 140 300 3.0
120 210 370 3.7
7 30 65 150 1.5
90 130 320 3.2
240* 570 1500 15
Data from the Swedish Metrological and Hydrological Institute (SMHI)
* The exposure time for Sunscreen 7 it was 30 min, 90 min and 240 min due to technical obstacles
** Data not available due to technical obstacles at SMHI.
Table 1: The photoactive compounds in the investigated sunscreens, CAS no and SPF of the product.
Photoactive compound CAS no Mainly protection against Active ingredients in the seven investigated sunscreen products
UVA UVB 1 2 3 4 5 6 7
EHMC 5466-77-3 x x x x
MBC 36861-47-9 x x x x
EHT 88122-99-0 x x
OC 6197-30-4 x x
BMDBM 70356-09-1 x x x x x x x
BZ-3 131-57-7 x x x
TLDCSA 90457-82-2 x x
TiO2 13463-67-7 x x x x x
ZnO 1314-13-2 x x
SPF 4 1 41 01 0 6 1 01 5
CAS Chemical Abstracts Service
EHMC ethylhexyl methoxycinnamate MBC 4-methylbenzylidene camphor
EHT ethylhexyl triazone OC octocrylene BMDBM butyl methoxydibenzoylmethane
BZ-3 benzophenone-3 TLDCSA terephthalylidene dicamphor sulfonic acid
TiO2titanium dioxide ZnO zinc oxide
SPF Sun Protection FactorBMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
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and 12 kJ/m2 of UV radiation (UVB included) and before
and after UVnat. If the AUCI (AUCI = AUCafter/AUCbefore)
was >0.80, the sunscreen was considered photostable.
The AUC was calculated with the following equation:
where A is absorption and λ is wavelength. It was meas-
ured in steps of 1 nm.
For UVA λmax = 400 nm and λmin = 320 nm. The same cal-
culation was done for each UV range respectively, before
and after UVart and before and after UVnat.
Maier et al. used the difference between the spectral trans-
mission before and after a defined UV exposure, ΔT. A
product was labeled photounstable if the mean photoin-
stability was higher than 5% (1 mg/cm2 product was
used) [9]. In our study we chose the AUCI instead. Since
we used 0.5 mg/cm2 we considered the product photosta-
ble if the AUCI was higher than 0.8.
Results
Sunscreens
The photostability of the sunscreens tested varies consid-
erably. The photounstable sunscreens start to degrade
rather rapidly when exposed to the sun. After 30 min of
UVnat, Sunscreens 1 and 3 are unstable (AUCI <0.80).
Sunscreens containing inorganic chemical filters are more
photostable in our study than sunscreens with organic
chemical filters with the exception of Sunscreens 3 and 5
Sunscreens 5, 6 and 7 are photostable after UVnat; in the
UVA range the AUCI was between 0.85 and 0.99 after 120
min and between 0.92 and 1.0 in the UVB range. Sun-
screen 4 shows in the UVA range an AUCI of 0.87 after
UVnat but 0.72 after UVart.
Sunscreens 1, 2 and 3 are unstable. They show after 90
min UVnat an AUCI between 0.41 and 0.76 in the UVA
range and between 0.30 and 0.69 in the UVA1 range.
Sunscreens 2, 4, 5, 6 and 7 are stable in the UVB region
whereas Sunscreens 1 and 3 are not. During exposure,
absorption ranges of Sunscreens 1, 2 and 3 are shifted
towards shorter wavelengths (Fig. 1a–c).
In Table 3 the AUCI is presented.
This is true for all three samples, after both UVnat and
UVart. Sunscreen 4 is more unstable after UVart than to
UVnat (Fig. 2).
The spectra were normalized by dividing the maximum
value of the spectrum before irradiation by itself, so that
the peak value of the spectrum before irradiation was set
to 1.
The temperature was higher, during exposure to the UVart
than during exposure to UVnat, but the temperature did
not influence the absorption. Sunscreens 5, 6 and 7 were
stable both after UVart and after UVnat. Sunscreens 6 and
7 were very little influenced by UV exposure (Fig. 3a–c). In
agreement with findings from other studies, sunscreens
with the UV filter combination ethylhexyl methoxycinna-
mate (EHMC) and butyl methoxydibenzoylmethane
(BMDBM) were unstable [6,9,21,22].
Discussion
In most cases UVnat compared to the UVart gave qualita-
tively similar results. However, UVnat, with a lower flu-
ence rate than UVart, gave similar yields of degradation. In
addition, the fluence rate of the UVAart was higher than
that of the UVAnat, which could be expected to degrade
the sunscreens faster. But this is not the case, except for
Sunscreen 4. Since the dose of UVAart was higher than
UVAnat, Sunscreen 4 probably provides sufficient protec-
tion for the consumer.
Commercial sunscreens generally have low viscosity in
order to be easy to apply. The temperature increase of the
samples during UV exposure, especially after UVart, may
lower the viscosity further. This may result in reductions
of the optical path lengths of the samples. However, this
was not the case in our study since samples kept on a heat-
ing plate for 20 min at 50°C showed a similar spectrum
before and after heating.
Four of the seven sunscreens contain TiO2. If the particles
are too small they may lose their scattering effect and, con-
sequently, not give as good protection as larger particles.
This may be the case for Sunscreen 5 (Fig. 3a). Several
other studies show that inorganic chemical filters are not
always photostable [6,9-11]. Our study indicates the
opposite, but seven sunscreens are a quite small amount
of material, so this finding should be interpreted with cau-
tion.
When mixed with petrolatum, some sunscreens undergo
degradation during exposure to UV radiation, especially
in the UVA range [5]. This is also the case for one of the
most frequently used UV filters BMDBM. This compound
is included in six of the seven sunscreens studied here
(Table 1). Our results confirm the findings from other
studies that sunscreens containing the combination of
EHMC and BMDBM are photounstable, regardless of
what other UV filters they contain [6,9].
A λλ λ
λ () ∑ Δ min
maxBMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
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UV absorbance spectra of UVA photounstable sunscreens (AUCI <0.80) Figure 1
UV absorbance spectra of UVA photounstable sunscreens (AUCI <0.80). Before and after natural UV exposure (UVnat), and 
before and after artificial UV exposure (UVart). (a) Sunscreen 1 (b) Sunscreen 2 (c) Sunscreen 3.
1.2
1
A
b
s
o
r
b
a
n
c
e
 
(
n
o
r
m
a
l
i
z
e
d
)
0.8
0.6
before UVnat
0.4 after 30 min UVnat
after 90 min UVnat
after 120 min UVnat
before UVart 0.2
after UVart
 UVB UVA2  UVA1
0
290 300 310 320 330 340 350 360
Wavelength (nm)
370 380 390 400
(a)
       UVB
1.2
A
b
s
o
r
b
a
n
c
e
 
(
n
o
r
m
a
l
i
z
e
d
)
1
0.8
0.6
before UVnat
0.4
after 30 min UVnat
after 90 min UVnat
after 120 min UVnat
before UVart
after UVart
0.2
UVA2      UVA1
0
290 300 310 320 330 340 350 360
Wavelenght (nm)
370 380 390 400
(b)
1.2
A
b
s
o
r
b
a
n
c
e
 
(
n
o
r
m
a
l
i
z
e
d
)
1
0.8
0.6
before UVnat
after 30 min UVnat
after 90 min UVnat
after 120 min UVnat
before UVart
after UVart
0.4
0.2
0
290 300 310 320 330
   UVB UVA2      UVA1
340 350 360 370 380 390 400
Wavelength (nm)
(c)BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
Page 6 of 9
(page number not for citation purposes)
Some manufacturers of sunscreens claim that commer-
cially available sunscreens are photostable because the
photoactive species are in a vehicle that stabilizes them.
This claim does not seem to be correct in several cases.
There are several studies about how improvement of pho-
tostability may be obtained, e.g. with nanoparticle encap-
sulation of EHMC [23], liposphere preparation of
BMDBM [24] or a combination with diethylhexyl
syringylidene malonate and BMDBM [25]. These findings
are very interesting and will hopefully lead to an improve-
ment in photostability in commercial available products.
When sunscreens without metallic oxide particles are
compared, Sunscreen 1 seems to be more rapidly
degraded than BMDBM dissolved in petrolatum. Not only
does the UVA protection decline after exposure, but also
the UVB protection. EHMC is one of the two UVB-absorb-
ing filters present in Sunscreen 2, and the only one in Sun-
screen 1. EHMC dissolved in petrolatum is rather
photounstable [5]. The vehicles of Sunscreens 1 and 2 are
nearly identical. The UVA-absorbing compound benzo-
phenone-3 (BZ-3) is added in Sunscreen 2. The presence
of this compound may stabilize BMDBM, in agreement
with earlier findings [26]. Another stabilizer that may
UV absorbance spectra of Sunscreen 4 Figure 2
UV absorbance spectra of Sunscreen 4. Before and after natural UV exposure (UVnat), and before and after artificial UV expo-
sure (UVart). Sunscreen 4 was photostable when exposed to natural UV in the UVA range but not to UVAart.
1.2
UVA2    UVA1
A
b
s
o
r
b
a
n
c
e
 
(
n
o
r
m
a
l
i
z
e
d
)
1
0.8
0.6
before UVnat
after 30 min UVnat
after 90 min UVnat
after 120 min UVnat
before UVart
after UVart
0.4
0.2
     UVB
0
290 300 310 320 330 340 350 360 370 380 390 400
Wavelength (nm)
Table 3: Summary of the AUCI values for the investigated sunscreens
After natural UV exposure After artificial UV exposure
Sunscreen UVA UVA1 UVA2 UVB UVA UVA1 UVA2 UVB
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
30 
min
90 
min
120 
min
1 0 . 7 20 . 4 60 . 3 60 . 6 90 . 3 80 . 2 90.83 0.65 0.54 0.91 0.87 0.81 0.36 0.32 0.45 0.69
2 0.84 0.76 0.75 0.83 0.69 0.67 0.86 0.92 0.97 0.86 0.92 0.97 0.63 0.53 0.88 0.89
3 0 . 6 70 . 4 10 . 4 10 . 5 90 . 3 00 . 3 40.81 0.58 0.52 0.92 0.75 0.63 0.40 0.31 0.58 0.73
4 0.92 0.86 0.87 0.91 0.85 0.83 0.94 0.91 0.91 0.95 0.93 0.95 0.72 0.69 0.81 0.83
5 0.96 0.89 0.85 0.94 0.87 0.83 0.99 0.95 0.93 0.99 0.99 0.98 0.90 0.88 0.97 0.97
6 0.98 0.94 0.94 0.97 0.93 0.93 0.98 0.96 0.97 0.99 0.99 1.00 0.85 0.82 0.92 1.00
7 0.99* 1.00* 0.96* 0.92* 0.99 0.99 1.00 0.99
The AUCI is defined as AUCafter/AUCbefore. The bold numbers show when AUCI is <0.80.
* Sunscreen 7 was exposed to natural UV during 240 min.BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
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UV absorbance spectra of UVA photostable sunscreens (AUCI >0.80) Figure 3
UV absorbance spectra of UVA photostable sunscreens (AUCI >0.80). Before and after natural UV exposure (UVnat), and 
before and after artificial UV exposure (UVart). (a) Sunscreen 5 (b) Sunscreen 6 (c) Sunscreen 7 was exposed to 240 min of 
UVnat.
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work is anisotrizine (CAS no 187393-00-6)is [27]; how-
ever, that compound was not included in any of the prod-
ucts in this study. Sunscreen 2 also has a higher SPF.
However, a degradation manifesting itself in the UVA1
region should be noted.
Sunscreen 5 is photostable but does not contain any
metallic oxide particles. This may be due to a vehicle that
successfully prevents degradation and/or due to micro-
structures of the emulsion itself (Fig. 3a). It is interesting
to compare this spectrum with that of Sunscreen 3 (Fig.
1c) which, according to the list of contents, includes TiO2
particles but does not show the scattering slope. The size
of the particles may be too small (15 nm, according to the
producer) to influence the absorption spectrum in the vis-
ible range. Small particles of TiO2 are expected to give
maximal scattering in the UVB or UVC region. Larger par-
ticles can cause significant scattering also in the UVA and
visible region. It follows that the small nanoparticles can-
not give good protection in the UVA region in this case.
The peak between 350 and 375 nm in the absorption
spectra of Sunscreens 3, 4 and 5 (Figs. 1c, 2, 3a) can be
attributed to BMDBM. In view of this it should be noted
that the UV exposure makes the products react quite dif-
ferently. In Sunscreen 3 the BMDBM peak almost vanishes
totally after 30 min of UVnat, while the peaks in the other
two sunscreens are more stable. We suggested above why
there could be degradation in the UVA range in Sunscreen
3 despite the presence of TiO2 particles. The reported sta-
bilizing effect of 4-Methylbenzylidene camphor (MBC)
[26] does not manifest itself in the case of Sunscreen 3.
The photostable Sunscreen 6 contains, in addition to
BMDBM and TiO2, a third UVA absorber, terephthalyli-
dene dicamphor sulfonic acid (TLDCSA), which can stabi-
lize BMDBM. It has also been shown that TiO2  may
stabilize ketoprofen and may be used in protecting phot-
ounstable species [28].
Many commercial sunscreens give, according to the man-
ufacturers, good UVA and UVB protection. However, the
photostability of the sunscreen in the UVA range is not
always adequate. Most sunscreens offer good protection
against UVB while the UVA photostability of some prod-
ucts decreases substantially during UV exposure. The
potential toxicity of the photoproducts also needs to be
investigated further.
For the consumer it is very difficult to know what product
to choose, since the photostability varies between differ-
ent brands and the photostability is not marked on the
bottle. To know which photoactive compound the sun-
screen contains is not good enough. The stability also
depends on factors like preservatives, oxygen radical scav-
engers, and base formulation. It is not reasonable that the
ordinary consumer should have knowledge of this. If the
product claims to give broadband protection, this protec-
tion should remain also after sun exposure. The fact that
sunscreens are photounstable has been known for many
years. Our study clearly shows that there are still many
photounstable products on the market. When buying a
sunscreen, the consumer should automatically receive a
photostable product.
Conclusion
The present study shows that several commercially availa-
ble sunscreens are not photo stable. Degradation is clearly
manifested in the absorption region in the UVA range
after solar irradiation. In general, sunscreens with TiO2
particles seem to be more photostable, with Sunscreens 3
and 5 as exceptions. Special focus should be on the com-
monly used UVA absorber BMDBM. In three out of six
sunscreens in our study this molecule was degraded dur-
ing UV exposure. Stabilizers of BMDBM may work, but
not under all conditions. There is a need for a standard-
ized method to measure photostability and the photosta-
bility should be marked on the sunscreen product.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
HG and NT-W have made contributions to conception of
design and interpretation of the data. They carried out the
experimental set-up during the absorption studies and
wrote the main part of the manuscript.
BS carried out some of the absorption studies and drafted
the manuscript.
AR have made substantial contributions to conception of
design, interpretation of the data and drafting and revis-
ing the manuscript. AR also participated in the coordina-
tion of the study.
AJ, JM, OL and A-MW have made substantial contribution
to concept of design and drafting and revising the manu-
script critically.
All authors read and approved the final manuscript.
Acknowledgements
We gratefully acknowledge financial support from the Swedish Research 
Council for Engineering Science (TFR, contract no. 98–797) and the 
Welander Foundation. We also thank Dr Jerker Mårtensson, at Chalmers 
University of Technology for fruitful discussion, and Tomas Landelius and 
Weine Josefsson at SMHI.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Dermatology 2007, 7:1 http://www.biomedcentral.com/1471-5945/7/1
Page 9 of 9
(page number not for citation purposes)
References
1. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, Marks GC,
Gaffney P, Battistutta D, Frost C, Lang C, Russell A: Daily sunscreen
application and betacarotene supplementation in preven-
tion of basal-cell and squamous-cell carcinomas of the skin: a
randomised controlled trial.  Lancet 1999, 354:723-729.
2. Bastuji-Garin S, Diepgen TL: Cutaneous malignant melanoma,
sun exposure, and sunscreen use: epidemiological evidence.
Br J Dermatol 2002, 146 Suppl 61:24-30.
3. Huncharek M, Kupelnick B: Use of topical sunscreens and the
risk of malignant melanoma: a meta-analysis of 9067
patients from 11 case-control studies.  Am J Public Health 2002,
92:1173-1177.
4. Moan J, Dahlback A, Setlow RB: Epidemiological support for an
hypothesis for melanoma induction indicating a role for
UVA radiation.  Photochem Photobiol 1999, 70:243-247.
5. Tarras-Wahlberg N, Stenhagen G, Larko O, Rosen A, Wennberg AM,
Wennerstrom O: Changes in ultraviolet absorption of sun-
screens after ultraviolet irradiation.  J Invest Dermatol 1999,
113:547-553.
6. Maier H, Schauberger G, Brunnhofer K, Honigsmann H: Change of
ultraviolet absorbance of sunscreens by exposure to solar-
simulated radiation.  J Invest Dermatol 2001, 117:256-262.
7. Haywood R, Wardman P, Sanders R, Linge C: Sunscreens inade-
quately protect against ultraviolet-A-induced free radicals in
skin: implications for skin aging and melanoma?  J Invest Der-
matol 2003, 121:862-868.
8. Marrot L, Belaidi JP, Lejeune F, Meunier JR, Asselineau D, Bernerd F:
Photostability of sunscreen products influences the effi-
ciency of protection with regard to UV-induced genotoxic or
photoageing-related endpoints.  Br J Dermatol 2004,
151:1234-1244.
9. Maier H, Schauberger G, Martincigh BS, Brunnhofer K, Honigsmann
H:  Ultraviolet protective performance of photoprotective
lipsticks: change of spectral transmittance because of ultra-
violet exposure.  Photodermatol Photoimmunol Photomed 2005,
21:84-92.
10. Serpone N, Salinaro A, Emeline AV, Horikoshi S, Hidaka H, Zhao J:
An in vitro systematic spectroscopic examination of the pho-
tostabilities of a random set of commercial sunscreen lotions
and their chemical UVB/UVA active agents.  Photochem Photo-
biol Sci 2002, 1:970-981.
11. Diffey BL, Stokes RP, Forestier S, Mazilier C, Rougier A: Suncare
product photostability: a key parameter for a more realistic
in vitro efficacy evaluation.  Eur J Dermatol 1997:226-228.
12. Moyal D, Refregier JL, Chardon A: In vivo measurement of the
photostability of sunscreen products using diffuse reflect-
ance spectroscopy.  Photodermatol Photoimmunol Photomed 2002,
18:14-22.
13. Diffey BL, Tanner PR, Matts PJ, Nash JF: In vitro assessment of the
broad-spectrum ultraviolet protection of sunscreen prod-
ucts.  J Am Acad Dermatol 2000, 43:1024-1035.
14. Lim HW, Naylor M, Honigsmann H, Gilchrest BA, Cooper K, Mori-
son W, Deleo VA, Scherschun L: American Academy of Derma-
tology Consensus Conference on UVA protection of
sunscreens: summary and recommendations. Washington,
DC, Feb 4, 2000.  J Am Acad Dermatol 2001, 44:505-508.
15. Nash JF, Tanner PR, Matts PJ: Ultraviolet A radiation: testing and
labeling for sunscreen products.  Dermatol Clin 2006, 24:63-74.
16. Moyal D, Wichrowski K, Tricaud C: In vivo persistent pigment
darkening method: a demonstration of the reproducibility of
the UVA protection factors results at several testing labora-
tories.  Photodermatol Photoimmunol Photomed 2006, 22:124-128.
17. Stokes R, Diffey BL: In vitro assessment of sunscreen photosta-
bility: the effect of radiation source, sunscreen application
thickness and substrate.  Int J Cosmetic Sci 1999, 21:341-351.
18. Josefsson W: Solar ultraviolet radiation in Sweden.  SMHI
Reports meteorology and climatology 1986.
19. CIE: Erythema reference action spectrum and standard ery-
thema dose, S007/E: ; Vienna, Austria.  ; 1998. 
20. Thieden E, Philipsen PA, Heydenreich J, Wulf HC: UV radiation
exposure related to age, sex, occupation, and sun behavior
based on time-stamped personal dosimeter readings.  Arch
Dermatol 2004, 140:197-203.
21. Bonda C, Marinelli P: The photochemistry of sunscreen photo-
stability: 3-4 Nov; Paris.  Step Publishing Ltd; 1999:46-51. 
22. Sayre RM, Dowdy JC, Gerwig AJ, Shields WJ, Lloyd RV: Unexpected
photolysis of the sunscreen octinoxate in the presence of the
sunscreen avobenzone.  Photochem Photobiol 2005, 81:452-456.
23. Perugini P, Simeoni S, Scalia S, Genta I, Modena T, Conti B, Pavanetto
F: Effect of nanoparticle encapsulation on the photostability
of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate.
Int J Pharm 2002, 246:37-45.
24. Iannuccelli V, Sala N, Tursilli R, Coppi G, Scalia S: Influence of lipo-
sphere preparation on butyl-methoxydibenzoylmethane
photostability.  Eur J Pharm Biopharm 2006, 63:140-145.
25. Chaudhuri RK, Lascu Z, Puccetti G, Deshpande AA, Paknikar SK:
Design of a photostabilizer having built-in antioxidant func-
tionality and its utility in obtaining broad-spectrum sun-
screen formulations.  Photochem Photobiol 2006, 82:823-828.
26. Wünsch T, Westenfelder H: New aspects in sunscreens: 17-18
Nov; Paris.  Step Publishing Ltd; 1998:56-60. 
27. Chatelain E, Gabard B: Photostabilization of butyl methoxy-
dibenzoylmethane (Avobenzone) and ethylhexyl methoxy-
cinnamate by bis-ethylhexyloxyphenol methoxyphenyl
triazine (Tinosorb S), a new UV broadband filter.  Photochem
Photobiol 2001, 74:401-406.
28. Loden M, Akerstrom U, Lindahl K, Berne B: Novel method for
studying photolability of topical formulations: a case study of
titanium dioxide stabilization of ketoprofen.  J Pharm Sci 2005,
94:781-787.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-5945/7/1/prepub